Insiders who reported open-market trades in the last 12 months at the companies Robert Hagemann files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Kevin R. Thornal - $529K in ZBH purchases and sales in the last 12 months
Sang Yi - $510K in ZBH purchases and sales in the last 12 months
Chad F. Phipps - $295K in ZBH purchases and sales in the last 12 months
Lori Winkler - $251K in ZBH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Robert Hagemann is a corporate insider, tracked as Director of ZIMMER BIOMET HOLDINGS, INC. (ZBH). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert Hagemann submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Robert Hagemann been buying or selling stock?
Recorded transactions: 1 open-market purchase ($154K) and 0 open-market sales across all tracked filings.
Robert Hagemann is Director of ZIMMER BIOMET HOLDINGS, INC. (ZBH). 13 SEC Form 4 filings on record going back to 2024, most recently on 2 October 2026. Most recent open-market trade: bought $154K of GPK on 11 May 2026. Lifetime open-market purchases: $154K.
Recent transactions
5
The latest 5 SEC Form 4 transactions reported by Robert Hagemann.
InsiderAlpha's records for Robert Hagemann go back to 2024: 13 primary Form 4 filings, an average of 4.3 per year. The typical open-market purchase is $154K (1 buy totaling $154K). The largest single buy on record is $154K of GPK in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
